Healthcare Industry
Filter News
Found 19,473 articles
-
Angle PLC Announces Breakthrough Clinical Results
1/4/2024
ANGLE plc is delighted to announce breakthrough results from DNA molecular analysis of cancer patient blood samples that provide a unique insight into the progression of each patient's cancer and how this may be treated.
-
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer
1/3/2024
Brii Biosciences Limited, a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, is pleased to announce the appointment of Dr. Brian Alvin Johns, Ph.D., as Chief Scientific Officer, effective January 3, 2024.
-
Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference
1/3/2024
Frontier Medicines Corporation announced that Chris Varma, Ph.D., Frontier’s co-founder, chairman, and CEO, will present a company overview at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 11:30 a.m. PT.
-
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference - Jan 03, 2024
1/3/2024
PureTech Health plc announced that Daphne Zohar, Founder and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 9:00 a.m. PST / 12:00 p.m. EST.
-
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
1/3/2024
Affimed N.V., a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that it has reached a definitive agreement to sell its wholly-owned subsidiary, AbCheck s.r.o., to Ampersand Biomedicines.
-
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
1/3/2024
Voyager Therapeutics, Inc. announced that Chief Executive Officer Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January 10, 2024, at 9:45 a.m. PT.
-
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
1/3/2024
InspireMD announced the appointment of medical technology executive Pete Ligotti as Executive Vice President and General Manager of North America.
-
Abbott Hosts Conference Call for Fourth-Quarter 2023 Earnings
1/3/2024
Abbott will announce its fourth-quarter 2023 financial results on Wednesday, Jan. 24, before the market opens.
-
STRATA Skin Granted Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
1/3/2024
STRATA Skin Sciences, Inc. announced that it has received a notification letter from Nasdaq Stock Market LLC that the Company has been granted a 180-day extension, or until June 24, 2024, to regain compliance with Nasdaq’s minimum bid price rule.
-
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 03, 2024
1/3/2024
ImmunoGen, Inc. announced that the compensation committee of the Company’s Board of Directors approved, effective as of December 29, 2023, the grant of restricted stock units covering 167,159 shares of ImmunoGen’s common stock under the ImmunoGen, Inc.
-
Foghorn Therapeutics Announces CFO Departure - Jan 03, 2024
1/3/2024
Foghorn® Therapeutics Inc. announced that Chief Financial Officer, Allan Reine will be departing the Company to pursue another opportunity.
-
Omnia Medical Announces Trial Date for Ongoing Litigation with PainTEQ
1/3/2024
Omnia Medical announced that a trial date has been set for October 2024 in its ongoing lawsuit with PainTEQ.
-
OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
1/3/2024
OPKO Health, Inc. announced that it is commencing a private offering of $200.0 million aggregate principal amount of its Convertible Senior Notes due 2029.
-
Select Medical Holdings Corporation Announces Potential Separation of Concentra
1/3/2024
Select Medical Holdings Corporation announced that its board of directors has approved a plan to pursue the separation of Select Medical's wholly-owned occupational health services business, Concentra Group Holdings Parent, LLC.
-
NYU Grossman School of Medicine and Sarah Lawrence College Launch Graduate Genomics Degree Program
1/3/2024
NYU Grossman School of Medicine's Vilcek Institute of Graduate Biomedical Sciences and Sarah Lawrence College announced the launch of a master's program in genome health analysis.
-
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
1/3/2024
Profound Medical Corp. announced preliminary unaudited revenues for the fourth quarter and full year 2023, and provided an update on the progress it is making with the commercialization of TULSA-PRO® in the United States.
-
Amid the Biden administration’s efforts to reduce drug prices, Reuters reported in an exclusive that several pharmaceutical companies will raise pharma prices in January 2024. -
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
1/2/2024
Inspira Technologies OXY B.H.N Ltd., a pioneer in life support technology with a vision to supersede traditional mechanical ventilators, has announced the signing of a non-binding Letter of Intent with Northwestern Memorial Hospital in Chicago, Illinois.
-
NovAccess Global Announces $10.7 Million Financing
1/2/2024
NovAccess Global Inc., a biomedical company developing novel immunotherapies for brain tumor patients, announced it entered into a securities purchase agreement with an affiliate of Sumner Global LLC for a total financing of $10.7 million.
-
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
1/2/2024
Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the first quarter of 2024 of $1.19 per share on the company’s common stock.